Insulin aspart, recombinant Subcutaneous and Pemetrexed Disodium
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pemetrexed Disodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pemetrexed
Brand name: Alimta
Synonyms: Pemetrexed, PEMEtrexed
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pemetrexed Intravenous
- Insulin aspart, recombinant Subcutaneous-Pemoline
- Insulin aspart, recombinant Subcutaneous-Penbutolol
- Insulin aspart, recombinant Subcutaneous-Penciclovir
- Insulin aspart, recombinant Subcutaneous-Penciclovir topical
- Insulin aspart, recombinant Subcutaneous-Penicillamine
- Pemetrexed Disodium-Insulin degludec
- Pemetrexed Disodium-Insulin Degludec (U-100) Prefilled Pens
- Pemetrexed Disodium-Insulin Degludec (U-100) Vials
- Pemetrexed Disodium-Insulin Degludec (U-200) Prefilled Pens
- Pemetrexed Disodium-Insulin degludec and liraglutide
- Pemetrexed Disodium-Insulin degludec and liraglutide Subcutaneous